A CD4 T-lymphocyte count determines eligibility for antiretroviral therapy (ART) in patients
recently diagnosed with HIV and also monitors the efficacy of ART treatment thereafter. ART …

The ability to rapidly identify immune cell subsets such as CD4 cells, which became possible
around the same time as the onset of the HIV/AIDS pandemic, was one of the greatest …

Background Data on the evolution of natural SIV infection in chimpanzees (SIVcpz) and on
the impact of SIV on local ape populations are only available for Eastern African …

As a result of successful antiretroviral treatment over the last 20 years, HIV has become
more of a chronic disease for practitioners to manage, requiring careful, but routine, clinical …

Background. CD4 count measures the degree of immunosuppression in HIV‐positive
patients. It is also used in deciding when to commence therapy, in staging the disease, and …

Infectious diseases affect the daily lives of millions of people all around the world, and are
responsible for hundreds of thousands of deaths, mostly in the developing world. Although …

Background Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the
management of HIV patients, particularly in determining eligibility to initiate antiretroviral …

The counting of CD4+ T lymphocytes is a clinical parameter used for AIDS diagnosis and
follow-up. As this disease is particularly prevalent in developing countries, simple and …

CD4 T‐cell counting was introduced in clinical laboratories shortly after the discovery of the
human immune deficiency virus (HIV) in the early eighties. In western clinical laboratories …

Abstract The Acquired Immune Deficiency Syndrome (AIDS) affects the life of millions of
people around the world. Although rapid and low cost screening tests are widely available …